关于印度粉样性病的临床观点:一个系统的文献综述
Sumeet Mirgh1, Uday Yanamandra2, Ganesh K Vishvanathan3
1Adult Hematolymphoid and BMT unit, Department of Medical Oncology, Tata Memorial Centre, ACTREC, Navi Mumbai, India; Adult Hematolymphoid and BMT Unit, Homi Bhabha National Institute (HBNI), Mumbai, India.
Clinical lymphoma, myeloma & leukemia
|June 19, 2025
概括
印度的 Amyloidosis 在年轻的患者中呈现,脏AA型是常见的,通常与结核病有关. 这一综述强调了诊断不足和需要更多的研究来改善患者的治疗结果.
科学领域:
- 医学研究 医学研究
- 临床诊断 临床诊断 临床诊断
- 公共卫生 公共卫生
背景情况:
- 粉症涉及不溶性蛋白纤维在组织中的沉积,导致各种症状.
- 有限的数据存在于印度的amyloidosis流行和特征.
研究的目的:
- 系统地审查印度关于粉样症的现有临床数据.
- 确定研究缺口和未来研究领域.
主要方法:
- 来自PubMed. 的关于印度粉样菌病 (1959-2023) 的英语文章的系统综述.
- 分析国际会议摘要. 分析国际会议摘要.
- 提取的数据包括amyloidosis类型,人口统计,临床特征,诊断和结果.
主要成果:
- 印度患者比西方患者年轻10年 (中位数为50岁);70%是男性.
- 脏干扰是最常见的 (AA型流行,通常是结核病的次要),其次是心脏 (40-50%).
- 局部性氨基粉症最常影响皮肤 (68%);AL氨基粉症导致了4%的偏蛋白质性神经病变.
结论:
- 印度的氨基粉症诊断不足,表现和原因各异.
- 回顾性研究占主导地位,显示出呈现和结果的变化.
- 了解疾病负担和推进研究对于改善印度患者的治疗结果至关重要.
相关概念视频
Amyloid Fibrils
9.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.9K
Alzheimer's Disease: Overview
684
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
684
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
42
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
42
Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
Aneurysm II: Clinical Manifestations and Diagnostic Studies
27
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
27


